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Abstract Mitochondrial dysfunction has been associated with
late onset neurodegenerative disorders, among which is
Machado–Joseph disease (MJD/SCA3). In a previous study,
using a transgenic mouse model of MJD, we reported a de-
crease in mitochondrial DNA (mtDNA) copy number and an
accumulation of the 3876-bp deletion with age and with phe-
notype development. We extended this study by analyzing the
pattern of mtDNA depletion and the accumulation of the 3876-
bp deletion in 12 older transgenic (TG) and 4 wild-type (wt)
animals, and by investigating the accumulation of somatic
mutations in the D-loop region in 76 mice (42 TG and 34
wt). mtDNA damage was studied in TG and wt mice at differ-
ent ages and tissues (blood, pontine nuclei, and hippocampus).
Results for older mice demonstrate an accumulation of the
mtDNA 3867-bp deletion with age, which was more pro-
nounced in TG animals. Furthermore, the tendency for
mtDNA copy number decrease with age, in all analyzed tissues
of TG and wt animals, was also confirmed. No point mutations
were detected in the D-loop, neither in TG nor wt animals, in
any of the tissues analyzed. Due to the absence of mtDNA
somatic mutations, we can suggest that mtDNA point mutation
accumulation cannot be used to monitor the development and
progression of the phenotype in this mouse model and likely in
any MJD mice model. The present results further confirm not
only the association between mtDNA alterations (copy number
and deletions) and age, but also between such alterations and
the expression of the mutant ataxin-3 in TG mice.
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Introduction
Over the past two decades, multiple studies have provided
evidence on the relevance of mitochondrial biology in neuro-
logical disorders (Martin 2010) as well as in the aging process
(Larsson 2010).Mitochondrial dysfunction is being extensively
studied in patients with adult onset neurodegenerative disorders
such as poly-Q-related ataxias, among which is Machado–
Joseph disease (MJD). MJD/SCA3 (OMIM 109150;
ORPHA98757) is caused by a mutation in ataxin-3, a protein
encoded by the ATXN3 gene (for a revision on MJD see
Bettencourt and Lima (2011)). Although some studies have
reported the presence of mitochondrial DNA (mtDNA) damage
in MJD patients (Liu et al. 2008; Yu et al. 2009; Zheng et al.
2012), the way by which mitochondrial impairment and oxida-
tive stress are actually involved in the onset and progression of
the disease is not clear. A previous study from our group
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(Kazachkova et al. 2013b), using 8-, 16-, and 24-week old
transgenic (TG) mice of MJD expressing the mutated ataxin-3
and displaying a motor phenotype (Silva-Fernandes et al.
2010), reported mtDNA depletion and an increase in the level
of the 3867-bp deletion (the homolog of the 4977-bp deletion in
humans, considered a marker of aging). Aiming to better un-
derstand the pattern of mtDNA damage in MJD, we extended
this previous study by (1) analyzing the pattern of mtDNA
depletion and the accumulation of the 3876-bp deletion in older
TG animals and comparing them with wild-type (wt) litter-
mates and (2) sequencing the D-loop, a mutation-prone region
of mtDNA (the most variable segment in mammalian mito-
chondrial genomes (Attardi and Schatz 1988; Druzhyna et al.
2008)), to investigate the pattern of accumulation of somatic
mutations in both TG and wt animals.
Material and Methods
Mouse Model and Experimental Design
ATG mouse model of the early stages of MJD (Mus musculus,
strain C57B1/6, line CMVMJD94) developed in the Lab of P.
Maciel was used in the present study (Silva-Fernandes et al.
2010). These TG mice ubiquitously express the full-length
mutant human ataxin-3 and display a motor phenotype. The
mouse model used also mimics some key features that are
common in MJD patients, namely CAG repeat instability, neu-
rological damage, and brain pathology (Silva-Fernandes et al.
2010). The sample selection of TG and wt mice is shown in
Table 1. Affected tissue corresponded to pontine nuclei (Pn) and
non-affected corresponded to hippocampus (Hp) as well as
blood (Bl) (Table 1). Overall, 180 samples were analyzed for
early age groups (90 TG and 90 wt) and 32 samples for late age
groups (24 TG and 8wt) (Table 1). A total of 76mice were used
to study the accumulation of somatic mutations (42 TG and 34
wt); the late age groupswere analyzed to study themtDNA copy
number and the 3867-bp deletion (12 TG and 4 wt).
The animals used in the present work were maintained in
accordance with European regulations (European Union
Directive 86/609/EEC). Animal facilities and the people di-
rectly involved in animal experiments were certified by the
Portuguese regulatory entity—Directorate General for
Veterinary Medicine. All protocols were approved by the joint
Animal Ethics Committee of the Life and Health Sciences
Research Institute, University of Minho and the Institute for
Molecular and Cell Biology, University of Porto, Porto,
Portugal.
DNA Isolation, PCR Amplification, and Sequencing
DNA was extracted using the Puregene DNA isolation kit
(Gentra Systems), and the size of the CAG tract was assessed
as previously described (Silva-Fernandes et al. 2010).
Mitochondrial D-loop (positions 15423 to 16299) was ampli-
fied using a new designed primer pair L15349 and H133
based on the M. musculus mitochondrion complete genome
reference sequence (NC_005089.1). As previously demon-
strated, low heteroplasmy levels can be detected with confi-
dence using an automated sequencing system, provided that a
Table 1 Sample selection of
transgenic (TG) and wild-type
(WT) mice used in the present
study (Pn pontine nuclei; Hp
hippocampus)
Mice Age (weeks) Number of
mice
Number of samples
Pn Hp Blood Total samples
TG Early age group 8 10 10 10 10 30
16 10 10 10 10 30
24 10 10 10 10 30
Total 30 30 30 30 90
Late age group 60 6 6 6 – 12
72 6 6 6 – 12
Total 12 12 12 – 24
Total number of mice 42 Total number of samples 114
WT Early age group 8 10 10 10 10 30
16 10 10 10 10 30
24 10 10 10 10 30
Total 30 30 30 30 90
Late age group 60 2 2 2 – 4
72 2 2 2 – 4
Total 4 4 4 – 8
Total number of mice 34 Total number of samples 98
J Mol Neurosci
Author's personal copy
good sequencing strategy and an accurate procedure of
heteroplasmy detection and validation are used (Ramos et al.
2013). Therefore, all samples were fully sequenced and puri-
fied using the BigDye® Terminator v3.1 Cycle Sequencing
Kit (Applied Biosystems) according to the manufacturer’s
instructions. Sequences were run in an ABI 3130XL sequenc-
er (Applied Biosystems) at the Servei de Genòmica,
Universitat Autònoma de Barcelona. Sequences were aligned
with the M. musculus mtDNA reference sequence
(NC_005089.1), using SeqScape v2.5 software (Applied
Biosystems). To exclude sequencing errors, heteroplasmic
authentication criteria previously described by Santos et al.
(2005) were applied.
Quantitative Real-Time PCR
Determination of the mtDNA copy number and quantitative
detection of the 3867-bp deletion were performed by
fluorescence-based quantitative real-time PCR (FQ-PCR) as
described by Kazachkova et al. (2013b).
Results and Discussion
mtDNA Depletion and 3867-bp Deletion Accumulation
To obtain a more complete picture of the pattern of mtDNA
damage (copy number and deletions), data published by our
group (Kazachkova et al. 2013b) were extended. In our pre-
viously published work, three age groups (8, 16, and
24 weeks) were analyzed for each tissue (Pn, Hp, and Bl), in
both TG and wt animals (Kazachkova et al. 2013b). In the
present work, we have analyzed Pn and Hp samples from
older animals, namely 60- and 72-week old TG and wt mice
(Table 1). The results obtained (Fig. 1a) confirmed the global
tendency for mtDNA copy number decrease with age.
Interestingly, TG animals presented a significantly more evi-
dent accumulation of the 3867-bp deletion than wt (Mann–
Whitney U Test: Z=2.74; p=0.0062) (Fig. 1b). Although not
significant, correlation between brain tissues in TG and wt
animals demonstrated a more evident copy number decrease
as well as a more evident accumulation of deletion in Pn, the
affected brain region (Fig. 2). The present results allow us to
confirm the presence of a statistically significant accumulation
of the 3867-bp deletion in TG mice; furthermore, we corrob-
orate the tendency for mtDNA copy number decrease in TG
mice previously reported by Kazachkova et al. (2013b).
Fig. 1 Correlation of mtDNA copy number and mtDNA deletion per-
centage with age (weeks). The line in the graph represents a polynomial
trend line. a mtDNA copy number versus age; b mtDNA deletion
percentage % versus age
Fig. 2 Correlation of mtDNA
copy number (a) and mtDNA
deletion percentage (b) with
mtDNA origin (tissue)
J Mol Neurosci
Author's personal copy
Analysis of Somatic Mutations in the Mitochondrial D-Loop
Sequence analysis of the mitochondrial D-loop of the
CMVMJD94mice and their wt littermates revealed the absence
of point mutations in all samples (Supplemental material).
Neither fixed mutations nor mutations in heteroplasmy were
observed in any of the affected or unaffected tissues
(Supplemental material). No differential pattern of mtDNA
point somatic mutation accumulation was thus observed be-
tween TG and wt mice. The results obtained indicate that the
murine pattern of mtDNA somatic mutation accumulation is
less pronounced than in humans, a finding in accordance with
most previous studies, which, with the exception of the work of
Khaidakov et al. (2003), reported an absence of mtDNA point
mutations in mice (Goios et al. 2007; Kazachkova et al. 2013a;
Song et al. 2005; Dai et al. 2005; Ameur et al. 2011; Ferris et al.
1983). In the study of Song et al. (2005), the authors analyzed
the D-loop in samples of brain, skeletal muscle, heart, and other
tissues from aged mice, but were unable to find point
mutations. Similar results were presented by Goios et al.
(2007); these authors found no mutations in the D-loop of 32
complete mitochondrial genomes of the 16 inbred strains
analyzed.
In humans, for the whole mtDNA molecule, the frequency
of point heteroplasmic individuals exceeds 24% (Ramos et al.
2013). Specifically, in the D-loop, 8.2% of individuals present
point heteroplasmy. Thus, in humans, one point heteroplasmy
is expected in each 12 individuals. Using this expectation, the
sample size needed to observe the presence of at least one
heteroplasmic individual, with 95 % of confidence, is 34. In
this sense, at least two heteroplasmic mice would be expected,
since 76 mice have been analyzed to study the accumulation
of somatic mutations (Table 1). Moreover, and given the
putative negative effect of the mutant ataxin-3 on mtDNA
integrity (Yu et al. 2009), higher frequencies of mtDNA point
heteroplasmy in TG animals compared to wt mice would be
expected. We can therefore conclude that the accumulation of
point mutations in the D-loop of the mtDNA is not an indica-
tor of mtDNA damage in the present and likely in any MJD
mice model, and therefore its utility in the study of the
involvement of mtDNA in MJD development is limited.
Final Remarks
Despite the differences between humans and mice, namely on
what concerns physiological properties, disease pathogenesis,
and life history, mouse models have been frequently used in
the understanding of the process of mitochondrial alterations,
mainly because they share genomic similarities. Kazachkova
et al. (2013a) performed a comparative revision of studies
focused on mtDNA damage (copy number alterations, accu-
mulation of deletions, and of point mutations) carried out in
humans and mice. The compilation showed consistent results
among studies with a similar pattern of mtDNA deletions for
humans and mice. Contradictory results, however, were re-
ported for copy number and mtDNA point mutations accu-
mulation (Kazachkova et al. 2013a).
Results from our study evidenced a pattern of mtDNA
damage consistent with that reported by Kazachkova et al.
(2013a). The presence of a statistically significant accumula-
tion of the 3867-bp deletion was evidenced in a mouse model
ofMJD, being in accordance with the tendency reported in the
revision of Kazachkova et al. (2013a). The absence of a
significant mtDNA copy number decrease would be in line
with the discrepancies observed among studies (Kazachkova
et al. 2013a); thus, further studies would be necessary to
elucidate this pattern. mtDNA point mutations accumulation
has been clearly associated with age in humans, but not in
mice (revised in Kazachkova et al. (2013a)); our study reports
the lack of mtDNA somatic mutations, either at fixed or
heteroplasmic level in TGmice, suggesting that mtDNA point
mutation accumulation is not a useful indicator to monitor the
development of the phenotype in the CMVMJD94 TGmodel.
We can postulate that a similar pattern could be observed in
mouse models of other neurodegenerative disorders, this hy-
pothesis requiring validation.
The present results further confirm not only the association
between mtDNA alterations (copy number and deletions) and
age, but also between such alterations and the expression of
the mutant ataxin-3 in TG mice.
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